Product image of Ovamex (Ganirelix) supplied by GNH India

Ovamex

Active Ingredient:
Ganirelix
Origin:
EU

Ovamex (Ganirelix)

Ganirelix, the active ingredient in Ovamex, is a GnRH antagonist presented as an injectable solution for subcutaneous use. It is employed to prevent premature luteinising hormone surges during assisted reproductive treatment cycles.
GNH India supplies Ovamex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Theramex Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ganirelix is used in assisted reproductive technology to modulate the hormonal pathway that controls ovulation.

  • Controlled ovarian stimulation: prevents premature LH surge during IVF cycles, allowing better timing of oocyte retrieval.
  • Assisted reproductive technology: improves synchronization of follicular development for embryo transfer.
  • In vitro fertilisation protocols: enhances control over the ovarian response to gonadotropins.

How It Works

  • Ganirelix competitively binds to gonadotropin‑releasing hormone (GnRH) receptors in the anterior pituitary, blocking GnRH‑mediated stimulation and thereby suppressing the release of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). This inhibition prevents premature ovulation during controlled ovarian stimulation protocols.

Side Effects

Ganirelix may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Injection site pain: mild discomfort at the site of subcutaneous administration.
  • Headache: occasional tension‑type headache.
  • Nausea: transient feeling of queasiness.
  • Abdominal discomfort: mild cramping or bloating.
  • Hot flushes: brief episodes of warmth.
  • Fatigue: general tiredness.

Serious or Rare Side Effects

  • Ovarian hyperstimulation syndrome: severe swelling and fluid shift in response to ovarian stimulation.
  • Allergic reaction: rash, itching, or anaphylaxis in rare cases.
  • Severe abdominal pain: may indicate ovarian torsion or cyst rupture.
  • Thromboembolic events: rare clot formation.
  • Ovarian cyst formation: persistent cysts requiring monitoring.
  • Severe hypersensitivity: swelling of face, lips, or throat.

Precautions & Warnings

When using Ganirelix, consider the following safety measures.

  • Pregnancy: avoid use in women who are already pregnant; the drug is intended for pre‑ovulatory control.
  • Breastfeeding: exercise caution as limited data are available on excretion in milk.
  • Allergy assessment: verify no hypersensitivity to ganirelix or formulation excipients.
  • Hormonal monitoring: regularly assess LH and estradiol levels during treatment.
  • Concomitant hormonal therapy: review other reproductive hormones for potential interactions.
  • Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Ganirelix can interact with other agents that affect the reproductive hormonal axis.

Major Interactions (Avoid)

  • GnRH agonists: concurrent use may counteract the antagonist effect.
  • Hormonal contraceptives: may reduce contraceptive efficacy.
  • Ovarian stimulation drugs: overlapping mechanisms can increase risk of hyperstimulation.

Moderate Interactions (Monitor Closely)

  • CYP450 modulators: may alter ganirelix metabolism; monitor response.
  • Anticoagulants: monitor for bleeding if ovarian hyperstimulation occurs.
  • Diuretics: watch for electrolyte shifts during fluid changes in hyperstimulation.

Frequently Asked Questions

Ovamex contains ganirelix, a GnRH antagonist that is used to prevent premature luteinising hormone surges during controlled ovarian stimulation in assisted reproductive technology, such as in vitro fertilisation cycles.

Ganirelix works by competitively binding to GnRH receptors in the pituitary gland, blocking the natural hormone’s action and thereby suppressing the release of LH and FSH, which prevents an early ovulation during ovarian stimulation protocols.

The dose of Ovamex is determined by the prescribing clinician based on the individual treatment protocol, ovarian response, and monitoring results. Specific dosing regimens are not provided here.

Ovamex is intended for use before ovulation and should not be administered to women who are already pregnant. Limited data exist on its excretion in breast milk, so caution is advised for breastfeeding mothers.

To order Ovamex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Ovamex (ganirelix) is a GnRH antagonist similar to cetrorelix; both prevent premature LH surges. Differences may include dosing schedules, formulation, and manufacturer pricing, but clinical efficacy in controlled ovarian stimulation is comparable.

Ovamex should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen. It should be used shortly after removal from the refrigerator and handled with aseptic technique.

Ovamex is supplied as a sterile injectable solution for subcutaneous injection. It is typically administered by a healthcare professional into the abdominal wall or thigh according to the treatment protocol.

Serious risks include ovarian hyperstimulation syndrome, severe allergic reactions (anaphylaxis), ovarian torsion or cyst rupture, and rare thromboembolic events. Patients should be monitored closely for these complications.

Ovamex should not be used by women who are already pregnant, have known hypersensitivity to ganirelix or any excipients, or have uncontrolled endocrine disorders that could be aggravated by GnRH antagonism.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ganirelix

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT